secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOXYTRAN, INC (BIXT)
CIK:        0001445815
Form:       8-K
Filed at:   2025-01-22T23:59:59+00:00
Accession:  0001493152-25-003136
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 8.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bioxytran secures $1.6M stock purchase with Triton Funds; management forfeits $460K salaries
--------------------------------------------------------------------------------

- Triton Funds LP commits up to $1.6M for up to 17.5M shares (19.9%) at lowest traded price 10 days prior to closing.
- Proceeds: $805,000 to extinguish an existing note; balance for pre-clinical/clinical trials and working capital.
- Management forfeits more than $460,000 in accrued salaries and expenses to support the transaction.
- Closing requires effectiveness of a Form S-1 registration statement to be filed within 7 days; Triton gets $35,000 admin fee.
- The deal follows Triton's prior investment; it aims to remove convertible note overhang and fund development.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1445815/000149315225003136/0001493152-25-003136-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1445815/000149315225003136/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-003136

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer